​***If you do not receive your event confirmation within 1 business day of RSVPing (above), check your email spam folder. The automated Luma email includes the Zoom info and cal invite.***

​Comm Convo pricing:

• ​Complimentary for T2B Pro and Student community members (log into your T2B account and access your promo code here)

• ​$40 for Basic members (access to live event only, not the recording)

​If you're not part of Ticket to Biotech, confirm you're eligible, and join before registering for this event:

​T2B Intake Form

​COMM CONVO: FIGHTING MISINFORMATION WITHOUT AMPLIFYING IT

​False claims about our science, products, and companies can spread faster than our corrections ever will. We're strategic advisors navigating an information environment where traditional correction methods often backfire. This spans misinformation shared without intent to deceive, disinformation deliberately created to mislead, and malinformation where true facts are weaponized to damage. The challenge isn't just whether to respond to misinformation, it's that our attempts to correct it can inadvertently amplify false claims, erode trust in accurate information, and make the problem worse. This Comm Convo opens a practical discussion about making strategic intervention decisions under pressure, and what approaches actually reduce harm without spreading the lies we're trying to counter.

​WHY ATTEND

• ​Assess when leadership pressure to "set the record straight" could actually amplify misinformation and damage credibility, and build frameworks for making strategic response decisions under time pressure.

• ​Navigate cross-functional dynamics when teams advocate for different response approaches—from immediate detailed corrections to strategic restraint—and build alignment that balances competing priorities.

• ​Equip your teams with approaches that counter false claims without repeating them, including prebunking strategies and building resilient information ecosystems before crises hit.

• ​Explore how response strategies are evolving beyond traditional fact-checking toward more sophisticated approaches that preserve trust and prevent inadvertent amplification.

​MEET OUR SPEAKERS

​Holly Campbell, Senior Director, Head of Corporate Communications at Foundation Medicine (Moderator)

​Holly Campbell is senior director and head of corporate communications for Foundation Medicine, an independent affiliate of the Roche Group. At Foundation Medicine, Holly oversees the team responsible for developing and executing the company's global internal and external communications strategy to promote, enhance and protect the company's vision, brand and reputation. She serves as a communications counselor to the Foundation Medicine executive team and is a primary spokesperson for the company. 

​Prior to joining Foundation Medicine, Holly led U.S. corporate communications teams at AstraZeneca and Takeda. Previously, she was a deputy vice president of public affairs for the Pharmaceutical Research and Manufacturers of America (PhRMA), the trade association representing the country's leading biopharmaceutical research companies and served in a variety of roles at large and small public relations firms.

​Megan Freeland, Founder and Chief Health Literacy Champion, StockRose Creative, LLC

​As a public health pharmacist with a career focused on 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐚𝐝𝐯𝐨𝐜𝐚𝐜𝐲, 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐞𝐧𝐠𝐚𝐠𝐞𝐦𝐞𝐧𝐭, 𝐚𝐧𝐝 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐜𝐨𝐦𝐦𝐮𝐧𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐞𝐝 𝐞𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭𝐬, Megan Freeland believes people deserve empathetic yet evidence-based information to inform their care — and that patients should shape healthcare decisions in return.

Her work centers on making complex medical and scientific information clear, usable, and actionable for patients and caregivers, particularly where comprehension directly impacts trust, engagement, and outcomes. Megan has led 𝐞𝐝𝐮𝐜𝐚𝐭𝐢𝐨𝐧-𝐟𝐨𝐫𝐰𝐚𝐫𝐝 𝐡𝐞𝐚𝐥𝐭𝐡 𝐜𝐨𝐦𝐦𝐮𝐧𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 across nonprofit and healthcare settings and 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐞𝐝 𝐰𝐢𝐭𝐡 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐀𝐝𝐯𝐨𝐜𝐚𝐜𝐲 𝐛𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 𝐭𝐞𝐚𝐦𝐬 𝐚𝐬 𝐚 𝐡𝐞𝐚𝐥𝐭𝐡 𝐥𝐢𝐭𝐞𝐫𝐚𝐜𝐲 𝐜𝐨𝐧𝐬𝐮𝐥𝐭𝐚𝐧𝐭, supporting patient advocacy and engagement initiatives within regulatory and clinical constraints.

On her podcast — 🎙️ Health Literacy IRL — Megan connects with biopharma, clinical research/CRO, health system, and healthcare leaders to surface real-world lessons on 𝐢𝐦𝐩𝐫𝐨𝐯𝐢𝐧𝐠 𝐨𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐚𝐧𝐝 𝐞𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞-𝐥𝐞𝐯𝐞𝐥 𝐡𝐞𝐚𝐥𝐭𝐡 𝐥𝐢𝐭𝐞𝐫𝐚𝐜𝐲 that ultimately improves outcomes for patients.

​Daniel Nardin, Executive Director and Founder, Amazônia Vox

​Daniel Nardin holds a degree in Journalism from the Federal University of Pará (UFPA) and a Master’s in Communication and Society from the University of Brasília (UnB). He was a fellow at the International Center for Journalists (ICFJ), a member of the Oxford Climate Journalism Network, and an instructor for the Solutions Journalism Network. With 20 years of experience in journalism and communication in the Amazon, he has worked in newsrooms as well as in the public and private sectors. He founded and leads the Amazônia Vox project, which produces solutions journalism and maintains a database of expert sources and freelance journalists from the Amazon. He is the winner of the 2024 Roche Global Health Journalism Award and the National Sebrae Journalism Award. Furthermore, he is a founding member of the Brazilian Association of Public Communication (ABCPública) and serves on the boards of the Association of Digital Journalism (AJOR) and the Association of Education Journalists (Jeduca).